Menu

Securities And Capital Markets

With competition escalating and regulation increasing, today’s business environment makes raising capital a significant challenge. Those intent on pursuing new paths to growth must uncover the opportunities in these changing times. We can help turn market uncertainty to your advantage.

Latest Insights, News, and Events

Latest Insights, News, and Events

Client Successes

Advised Mohawk Group Holdings, Inc., a rapidly growing technology-enabled consumer products company, on its IPO on the Nasdaq Capital Market

Represented Unibail-Rodamco-Westfield, one of the world's premier developers and operators of flagship shopping destinations, in the issuance of US$750 million of 2.875% Guaranteed Senior Notes due 2027 pursuant to Rule 144A and Regulation S.

Advised Credit Suisse, Citigroup, Barclays, BNP Paribas, Crédit Agricole CIB, Deutsche Bank Securities, Goldman Sachs, J.P. Morgan, Morgan Stanley, RBC Capital Markets, Scotiabank, TD Securities and Wells Fargo in connection with the $1.25 billion tap senior notes issued by CSC Holdings, LLC, a subsidiary of Altice USA, one of the largest broadband communications and video services providers in the United States.

Represented Brazilian fintech company PagSeguro in their SEC-registered follow-on equity offering, which raised more than $653 million and is believed to be one of the largest equity offerings in Brazil for 2019

Advised the underwriters and international placement agents on Locaweb's IPO on the B3, the Brazilian stock exchange, consisting of the offering of 67,841,038 common shares, which generated estimated net proceeds of R$1,170 million.

Advised Jinshang Bank, the only provincial city commercial bank in Shanxi Province in China, in its US$422 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange.

Advised China Vanke on its approximately US$1 billion placing of new H shares.

Advised Morgan Stanley, Goldman Sachs and China Merchant Securities as the joint sponsors on the global offering and Hong Kong IPO of Ascletis Pharma, the first biotech company listing under the new Chapter 18A

Advised the biopharmaceutical Swiss company GeNeuro, along with underwriters Bryan Garnier & Co and Société Générale, on GeNeuro’s IPO, the first ever IPO of a Swiss company on the regulated market of Euronext in Paris

Advised Morgan Stanley and J.P. Morgan on the Jose Cuervo IPO on the Mexican Stock Exchange, the largest IPO out of Mexico in 2017.

How Do You Raise Capital?

We work with companies navigating every stage of the capital raising process, and advise issuers, underwriters, and other financial institutions on all types of equity and debt capital raisings. Our lawyers advise clients throughout Asia, Europe, Latin America, and the U.S. on a wide range of transactions under the laws of multiple jurisdictions. Our knowledge and understanding of local conditions helps them master the dynamics of today’s markets.

We also help ensure compliance with securities laws, securities exchange rules, and the corporate governance requirements of the U.S. Sarbanes-Oxley Act and Dodd-Frank Act.

A LEADING GLOBAL SECURITIES AND CAPITAL MARKETS PRACTICE

  • Paul Hastings’ Securities and Capital Markets practice assists clients to navigate every stage of the capital raising process. We provide advice to issuers, underwriters, and other financial institutions on all types of equity and debt capital raisings.
  • Our lawyers are experts in initial public offerings (IPOs), follow-on offerings, rights offerings, direct public offerings, bought deals, confidentially mandated offerings, at-the-market primary and secondary offerings, securities exchange listings, private placements (including Rule 144A and Regulation S offerings), PIPE offerings, block trades, convertible offerings and related equity derivatives, exchange offers and high-yield, mezzanine, and investment-grade debt offerings.
  • Our lawyers are well-versed in helping clients to ensure compliance with securities laws, securities exchange rules, and the corporate governance requirements of the U.S. Sarbanes-Oxley Act and Dodd-Frank Act.
  • We have a fully integrated debt capital markets and bank finance expertise. This allows us to offer clients seamless execution in bank/bond structures, whether within a single jurisdiction or in cross-border transactions.

RECOGNITION FOR OUR PRACTICE

  • Deal of the Year 2019, for the firm’s work on Jinxin Fertility’s Hong Kong IPO— China Business Law Journal, 2019
  • Deal of the Year 2019, for the firm’s work on CanSino Biologics’s Hong Kong IPO— China Business Law Journal, 2019
  • One of the Most Innovative Deals 2019 for the firm’s work on Fosun Tourism Group’s Hong Kong IPO— Financial Times Innovative Lawyers Asia-Pacific Report, 2019, *Also awarded “Deal of the Year 2019” by China Business Law Journal
  • Deal of the Year 2018 for the firm’s work on Ascletis Pharma’s Hong Kong IPO— China Business Law Journal, 2018
  • Capital Markets Tax Deal of the Year in the Americas — International Tax Review, 2018
  • Equity Market Deal of the Year — Asian Legal Business, 2018
  • Capital Markets Tax Deal of the Year in the Americas — International Tax Review, 2018
  • Capital Markets Firm of the Year — China Business Law Journal, 2017
  • Recognized by Chambers, Legal 500 and other industry guides for our global capabilities.

Spotlight